<DOC>
	<DOCNO>NCT01412489</DOCNO>
	<brief_summary>The purpose study evaluate intrauterine adhesion rate application HYALOBARRIER Gel end hysteroscopic myomectomy . Secondary endpoint tolerance side effect subsequent fertility .</brief_summary>
	<brief_title>Intrauterine Adhesion Rate After Hysteroscopic Myomectomy Application HYALOBARRIER Gel</brief_title>
	<detailed_description>Hysteroscopic myomectomy referent surgical treatment submucous myoma . But intrauterine adhesion rate evaluate 7 15 % procedure . The investigator hypothetically believe application HYALOBARRIER Gel end procedure , could reduce mean intrauterine rate 50 % . Thus , investigator perform multicenter ( n = 20 ) prospective study non randomized 220 patient submucous myoma &lt; 3 cm diameter , evaluate preoperative ultrasound . The investigator prefer study design , principal reason number enrol patient 200 patient group double blind randomized study . Now , patient , hysteroscopic myomectomy perform technique center ( bipolar coagulation physiologic serum ) , diagnostic hysteroscopy perform 2 month determinate existence intrauterine adhesion . Secondary end point study tolerance side effect HYALOBARRIER Gel subsequent fertility 2 year .</detailed_description>
	<criteria>18 45 agedpatients hysteroscopic diagnosis one submucous myoma le 3cm diameter require operative hysteroscopy saline type 0 , 1 2 negative plasmatic Î²HCG test non opposition patient social security multiple submucous myoma type 0 , 1 2 presurgical embolization presurgical impregnation GnRH agonist coagulative disorder malignancy uncontrolled diabetes operative hysteroscopy glycine know hypersensitivity HyalobarrierR Gel Endo infection surgical area concern</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uterine synechiae</keyword>
	<keyword>HyalobarrierR Gel Endo</keyword>
	<keyword>Operative hysteroscopy</keyword>
	<keyword>submucous myoma</keyword>
</DOC>